27 November 2023
What is contrast theory?
Read more
How can we help you today?
Our modern visual
environment is artificial contrast
Diffusion Optics Technology™
Introducing DOT™
Diffusion Optics Technology™ integrates thousands of light scattering elements called dots that mimic more natural contrast at all distances.
The first spectacles lenses that have demonstrated significant reduction of myopia progression over 36 months in a multi centre, multi-ethnicity study with children as young as 6 years old².
Key Figures
Clinically proven results
75%
«DOT™ 0.2» lenses slow myopia progression by up to 75% after 12 months of wear across diverse populations*
*Patient population aged 6–10 years (CYPRESS) and 6–13 years (CATHAY). Lenses were worn 10 hours per day.
Ref: 1. Rappon et al. Br J Ophthalmol 2023;107:1709-1715. 2. Laughton et al. Invest. Ophthalmol. Vis. Sci. 2025;66(8):2815
Ref: 1. Rappon et al. Br J Ophthalmol 2023;107:1709-1715. 2. Laughton et al. Invest. Ophthalmol. Vis. Sci. 2025;66(8):2815
59%
Reduced myopia progression by 59% over 2 years when worn full time*
*Full time wear determined from analysis based on parent responses to in office question 'Does your child remove their spectacles for any near vision activities?
REF: SGV Data on file 2021
REF: SGV Data on file 2021
93%
Children say they love their DOT glasses*
*Proportion agreeing to “I love my dot glasses" at the 30-day visit.
REF: SGV Data on file 2021. Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study, 24-month results (n = 256, 14 North American sites).
REF: SGV Data on file 2021. Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study, 24-month results (n = 256, 14 North American sites).
Highlights
Please note that our products are not available for sale or distribution in every country in the world.
Our products are not available for sale in the U.S.
REFERENCES
(1) Rappon J, et al. Br J Ophthalmol Epub ahead of print: 01/09/22
(2) SGV Data on file 2022